Edward J. Dulac III, EVP, Chief Financial Officer at Intellia Therapeutics, Inc. (NTLA), sold 6,379 shares at $9.21 ($59K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Open-market sale of $59k NTLA by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2025-07-25 | $209K | — | Filing → |
| FATE | SELL | 2024-03-05 | $19K | — | Filing → |
| FATE | SELL | 2024-01-30 | $9K | — | Filing → |